Medifast (MED) Other Non-Current Assets (2010 - 2026)

Medifast (MED) has 17 years of Other Non-Current Assets data on file, last reported at $6.9 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 21.47% year-over-year to $6.9 million; the trailing twelve-month figure through Mar 2026 stood at $6.9 million (down 21.47% YoY), and the FY2025 full-year result was $7.8 million, down 19.02% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $6.9 million, down from $7.8 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $15.8 million in Q3 2023 and bottomed at $6.9 million in Q1 2026.
• The 5-year median for Other Non-Current Assets is $12.0 million (2022), against an average of $11.4 million.
• The widest annual swing landed in 2022, when Other Non-Current Assets jumped 286.44%; it then sank 36.07% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $12.5 million in 2022, then grew by 17.61% to $14.6 million in 2023, then tumbled by 34.01% to $9.7 million in 2024, then declined by 19.02% to $7.8 million in 2025, then decreased by 12.47% to $6.9 million in 2026.
• The last three Other Non-Current Assets figures came in at $6.9 million (Q1 2026), $7.8 million (Q4 2025), and $7.0 million (Q3 2025), per Business Quant data.

Peer Comparison